Fresh analysis indicates that patients who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who stop traditional lifestyle programs.
Published data in a leading medical journal shows that while overweight people can lose a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals buying such medications should be aware of the danger of rapid rebound weight gain when the treatment is stopped," stated lead investigator Dr. Susan Jebb.
Such speed of recovery means a return to pre-treatment weight within about a year and a half.
Analyzing Therapies
The study, which looked at dozens of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with older methods.
The team point out that people who lose weight through diet and exercise usually have a slower creep back—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Doctors propose the mechanism of the injections accounts for the heightened rebound.
GLP-1 drugs imitate a body's own chemical called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels far above than normal may cause the body to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' results in hunger is unsuppressed, making excessive eating much more probable."
A Chronic Condition?
Health authorities advise the jabs for individuals with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts contend that, given the significant potential of relapse, the treatment might need to be life-long.
This perspective is reinforced by pharmaceutical companies, who state that the results "highlight the chronic character of excess weight," akin to managing conditions like hypertension.
User Experiences
Individuals who have come off the jabs explain a intense return of cravings.
"I experienced something flipping and I was suddenly starving," said one woman.
This difficulty is worsened if patients have not developed lasting lifestyle or habit modifications during therapy.
Widespread Interest
Survey data suggest that millions of adults in the UK have tried these injections in the past year, with interest continuing to grow.
- Use is greater among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the medications through private prescriptions rather than public health services.
Ultimately, clinicians stress that while GLP-1 drugs are powerful agents for weight loss, they are not a standalone solution and long-term success relies on integrated behavioural management.
